🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

⭐ The latest issue of Gastro Hep Advances is out! 🔗 ow.ly/oyWc50VOoqw

🔥 Check out the Editor's Essential Reading from the newest issue! 📖 Comparative Efficacy of NAFLD Therapies and Biomarker Associations: A Meta-Analysis Based on Liver Fat Content 🔗 ow.ly/gA1Y50VOoxx

⭐FEATURED ARTICLE⭐ 📰 Iodine-131 Combined With Plasma Exchange Treatment in Graves’ Hyperthyroidism Patients With Severe Liver Injury Whose Average Model for End-Stage Liver Disease Scores >20 👨‍⚕️ @zhengiianminghs; xingguangluo 🔗 ow.ly/IUZs50VOoNq

Thank you to everyone who attended the American Gastroenterological Association (AGA) reviewer session as part of #DDW2025 👩‍⚕️📖 Please don't hesitate to reach out if you would like to learn more about getting involved with peer review! 💡 Additional resources: ow.ly/bAes50VQarf ow.ly/4wZ250VQarh

The American Gastroenterological Association (AGA) journal editors loved seeing you at #DDW2025 ✅ Thank you to all who stopped by to meet the editors! 🤝 We can’t wait until to read your manuscript 📜 For more about the AGA journals: ow.ly/BzqC50VQaOH

⭐ This study reveals absorptive and barrier alterations in the duodenal epithelium from MASH patients using organoid technology. 👨‍⚕️ GHoPaT @aliaHadefi Eric Trépo 🔗 ow.ly/Zo7350VRanb

⭐ Check out this featured research letter from the latest issue of Gastro Hep Advances! 📜 A Feasibility Study to Determine History of Advanced Colorectal Polyps Among First-Degree Relatives of Early-Onset Colorectal Cancer Patients 🔗 ow.ly/wQWu50VRaMg

⭐ FEATURED ARTICLE ⭐ 📰 Effect of Risankizumab Induction and Maintenance Therapy on the Rate of Hospitalization in Patients with Crohn’s Disease 🔗 ow.ly/jNOU50VRaT6

Check out our systematic review comparing Adalimumab and Infliximab for perianal Crohn's disease, published in Gastro Hep Advances, an official American Gastroenterological Association (AGA) journal. Thank you Dr David T. Rubin, Dr. Benjamin McDonald, Dr. Khaled Abdeljawad, Dr. John Guardiola and Azizullah Beran, MD, ABOM-D

Today is #WorldIBDDay and we join IBD warriors, health care providers, researchers, & caretakers to raise awareness & make #IBDvisible! Use these toolkits to help guide your care for patients. 💜 #Crohns toolkit: ow.ly/1kQQ50VUiMn. 💜 #UC toolkit: ow.ly/TGOy50VUiMm.

📸 A 77-year-old female was found to have massive gastric dilation due to recurrent benign idiopathic pre-pyloric stenosis and was managed with lumen-apposing metal stent. She underwent endoscopic dilation of the pre-pyloric stenosis just 1 month prior. 🔗 ow.ly/eStZ50VVX7w

🔔 From an original research article, "fCD affects up to 50% of people with Crohn’s Disease over their lifetime...This study explores demographic, disease and treatment factors in a real-world Australasian cohort." 👀 Take a look! 🔗 ow.ly/yVJ250VVZ0C

For World Eosinophilic Esophagitis Day, we’ve curated a list of recent #EoE articles from across the journal portfolio: 🟣 ow.ly/lavM50VXnrF 🟣 ow.ly/Z2La50VXnrA 🟣 ow.ly/WQ3G50VXnrx 🟣 ow.ly/cePC50VXnrw 🟣 ow.ly/XBT650VXnrH #EoEDay American Gastroenterological Association (AGA)

📗 Check out Systematic Reviews and Meta-analysis from the latest issue! ⭐ Short-Term Outcomes of Endoscopic Ultrasound-Guided Pancreatic Cyst Ablation: A Systematic Review and Meta-Analysis 🔗 ow.ly/YYq350VVZAb

#ICYMI, we launched the AGA Quick Submit process for Original Articles and Research Letters. Benefits include: ✅Fewer additional information questions at submission ✅Focus on content/suitability rather than formatting 👩‍⚕️Submit today: ow.ly/EMfj50VXXy9 American Gastroenterological Association (AGA)

GHA May 2025: Gastro Hep Advances #GHADigest 💊Meta-analysis: Adalimumab vs. Infliximab in Perianal Crohn's 🔍 1⃣20% of Crohn’s Disease (CD) pts➡️perianal disease 2⃣Perianal fistula = most common subtype 3⃣High morbidity &⬇️QOL 4⃣Anti-TNF agents = first-line, but which is best🤷‍♂️❓

⭐ The Index of Severity for Eosinophilic Esophagitis (I-SEE) has a new app for point-of-care use. This study has tested and confirmed usability across adult and pediatric GI and Allergy providers. ⭐ Check out this article and the app, AGA-I-SEE. 🔗 ow.ly/LH7b50VXS77

📑 SLD, including metabolic-dysfunction and alcohol-associated etiologies, is an increasingly common indication for liver transplantation among younger adults (18-39 years), women, and Hispanic patients. 👨‍⚕️ Shyam Patel, Robert Wong, MD, MS, FAASLD, FACG 🔗 ow.ly/nM5G50VXSiY

❓ How do antiplatelet and anticoagulant medications impact multitarget stool DNA testing for #CRC? ⭐ This study found no significant effect on its positive predictive value for advanced adenomas. 👨‍⚕️ Mayo Clinic Gastroenterology & Hepatology 📣 Read more! 🔗 ow.ly/Oztl50VXSJq

⭐ Check out this research letter 👀 📩 Racial Disparities of Alcohol-Associated Liver Disease and Its Complications in Hospitalized Patients With Alcohol Use Disorder 🔗 ow.ly/T7Rv50W1P3i